Erythrocin Stearate (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Erythrocin Stearate drug offered from KAISER FOUNDATION HOSPITALS. This Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: ERYTHROMYCIN STEARATE
SUBSTANCE NAME: ERYTHROMYCIN STEARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-01-06
END MARKETING DATE: 0000-00-00


Erythrocin Stearate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionErythrocin Stearate from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2012-01-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0105_2118df83-73ab-4150-babc-8b48aacd80af
PRODUCT NDC: 0179-0105
APPLICATION NUMBER: ANDA060359

Other ERYTHROMYCIN STEARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
A-S Medication SolutionsErythrocin Stearate
Arbor Pharmaceuticals, Inc.Erythrocin Stearate
Blenheim Pharmacal, Inc.Erythrocin Stearate
Bryant Ranch PrepackErythrocin Stearate
KAISER FOUNDATION HOSPITALSErythrocin Stearate
PD-Rx Pharmaceuticals, Inc.Erythrocin Stearate